Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Holiday Inn London - Regent's Park

01 feb 2016 8:00 a.m. - 05 feb 2016 1:00 p.m.

Carburton Street , London, W1W 5EE, United Kingdom

Joint MHRA/DIA Excellence in Pharmacovigilance

This course is designed to provide a firm grounding in key aspects of European Clinical Pre- and Post-Marketing Safety regulatory requirements.

TOPIC 2 SESSION 1 CONTINUED: SUSAR Reporting in Clinical Trials and Case Studies

Session Chair(s)

Gaby L. Danan, MD, PHD

Gaby L. Danan, MD, PHD

Pharmacovigilance Expert

GLD, France

Phil  Tregunno

Phil Tregunno

Deputy Director - Patient Safety Monitoring

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Speaker(s)

Gaby L. Danan, MD, PHD

SUSAR Reporting in Clinical Trials and Case Studies

Gaby L. Danan, MD, PHD

GLD, France

Pharmacovigilance Expert

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.